Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities
4-Methylbenzimidazole 1-28 novel derivatives were synthesized and evaluated for their antiglycation and antioxidant activities. Compounds 1-7 and 11 showed excellent activities ranged 140-280 μM, better than standard drug rutin (294.46 ± 1.50 μM). Compound 1-28 were also evaluated for DPPH activitie...
Published in: | European Journal of Medicinal Chemistry |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Elsevier Masson SAS
2014
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905161829&doi=10.1016%2fj.ejmech.2014.07.078&partnerID=40&md5=bf97c4e0f2f2d9107b8b4ff76f9ebc45 |
id |
2-s2.0-84905161829 |
---|---|
spelling |
2-s2.0-84905161829 Taha M.; Ismail N.H.; Jamil W.; Rashwan H.; Kashif S.M.; Sain A.A.; Adenan M.I.; Anouar E.H.; Ali M.; Rahim F.; Khan K.M. Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities 2014 European Journal of Medicinal Chemistry 84 10.1016/j.ejmech.2014.07.078 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905161829&doi=10.1016%2fj.ejmech.2014.07.078&partnerID=40&md5=bf97c4e0f2f2d9107b8b4ff76f9ebc45 4-Methylbenzimidazole 1-28 novel derivatives were synthesized and evaluated for their antiglycation and antioxidant activities. Compounds 1-7 and 11 showed excellent activities ranged 140-280 μM, better than standard drug rutin (294.46 ± 1.50 μM). Compound 1-28 were also evaluated for DPPH activities. Compounds 1-8 showed excellent activities, ranging 12-29 μM, better than standard drug n-propylgallate (IC50 = 30.30 ± 0.40 μM). For superoxide anion scavenging activity, compounds 1-7 showed better activity than standard n-propylgallate (IC50 = 106.34 ± 1.6 μM), ranged 82-104 μM. These compounds were found to be nontoxic to THP-1 cells. © 2014 Elsevier Masson SAS. All rights reserved. Elsevier Masson SAS 2235234 English Article |
author |
Taha M.; Ismail N.H.; Jamil W.; Rashwan H.; Kashif S.M.; Sain A.A.; Adenan M.I.; Anouar E.H.; Ali M.; Rahim F.; Khan K.M. |
spellingShingle |
Taha M.; Ismail N.H.; Jamil W.; Rashwan H.; Kashif S.M.; Sain A.A.; Adenan M.I.; Anouar E.H.; Ali M.; Rahim F.; Khan K.M. Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities |
author_facet |
Taha M.; Ismail N.H.; Jamil W.; Rashwan H.; Kashif S.M.; Sain A.A.; Adenan M.I.; Anouar E.H.; Ali M.; Rahim F.; Khan K.M. |
author_sort |
Taha M.; Ismail N.H.; Jamil W.; Rashwan H.; Kashif S.M.; Sain A.A.; Adenan M.I.; Anouar E.H.; Ali M.; Rahim F.; Khan K.M. |
title |
Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities |
title_short |
Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities |
title_full |
Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities |
title_fullStr |
Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities |
title_full_unstemmed |
Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities |
title_sort |
Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities |
publishDate |
2014 |
container_title |
European Journal of Medicinal Chemistry |
container_volume |
84 |
container_issue |
|
doi_str_mv |
10.1016/j.ejmech.2014.07.078 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905161829&doi=10.1016%2fj.ejmech.2014.07.078&partnerID=40&md5=bf97c4e0f2f2d9107b8b4ff76f9ebc45 |
description |
4-Methylbenzimidazole 1-28 novel derivatives were synthesized and evaluated for their antiglycation and antioxidant activities. Compounds 1-7 and 11 showed excellent activities ranged 140-280 μM, better than standard drug rutin (294.46 ± 1.50 μM). Compound 1-28 were also evaluated for DPPH activities. Compounds 1-8 showed excellent activities, ranging 12-29 μM, better than standard drug n-propylgallate (IC50 = 30.30 ± 0.40 μM). For superoxide anion scavenging activity, compounds 1-7 showed better activity than standard n-propylgallate (IC50 = 106.34 ± 1.6 μM), ranged 82-104 μM. These compounds were found to be nontoxic to THP-1 cells. © 2014 Elsevier Masson SAS. All rights reserved. |
publisher |
Elsevier Masson SAS |
issn |
2235234 |
language |
English |
format |
Article |
accesstype |
|
record_format |
scopus |
collection |
Scopus |
_version_ |
1809678488752357376 |